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Treatment of cultured human fibroblasts with trifluoperazine or chlorpromazine resulted in a biphasic 
effect on low density lipoprotein (LDL) catabolism, depending upon the dose. At up to 10e5 M, a marked 
increase in LDL binding, internalization and degradation was observed. This phenomenon took place 
within the first hours of incubation with the drugs, suggesting a direct effect on cell membrane physical 
characteristics, probably related to the lipophilic properties of phenothiazines. Concentrations above 
2 x lo-’ M resulted in a relative decrease in LDL binding and internalization, and in a dramatic decrease 
in LDL degradation, which may be related to an inhibition of calmodulin-dependent processes. 
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1. INTRODUCTION 
In [l-3], low density lipoprotein (LDL) cata- 
bolism is mainly achieved by receptor-mediated en- 
docytosis, which results in lysosomal degradation 
and decrease in both endogenous sterol synthesis 
and LDL receptor expression. Calcium is generally 
required for LDL processing by cells, and it has 
been demonstrated that calmodulin is probably in- 
volved in receptor-mediated endocytosis [4]. More 
recently, authors in [5] found an inhibitory effect 
of the calmodulin effector trifluoperazine (TFP) 
on the acetylated-LDL degradation by liver cells, 
suggesting a role of calmodulin in LDL metabo- 
lism. 
We here investigated the effects of two pheno- 
thiazines, chlorpromazine (CPZ) and TFP, on 
LDL binding, internalization and degradation by 
cultured human fibroblasts. For the two drugs 
studied, we report a ‘biphasic’ phenomenon, 
depending upon the dose: at low concentrations 
(10-6-10-5 M), strong stimulation of both LDL in- 
ternalization and degradation was observed, 
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whereas a decrease of these processes was found 
for concentrations over 2-3 x lo-’ M. The LDL 
binding to their specific receptors was less af- 
fected. These results are discussed in relation to the 
effects of CPZ and TFP on calmodulin-dependent 
processes, and to the lipophilic properties of these 
drugs. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
MRCS (human fetal lung) fibroblasts purchased 
from Biomerieux were cultivated in 60-mm Petri 
dishes containing Ham FlO medium supplemented 
with 10% fetal calf serum (Gibco), at 37”C, in a 
humidified 5% CO2 atmosphere. Experiments 
were performed on confluent cells. 
2.2. Effects of drugs on LDL binding, internaliza- 
tion and degradation 
Prior to experiments, cells were incubated 24 h 
in a medium containing 10% lipoprotein-deficient 
serum, for maximal expression of LDL receptors. 
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CPZ and TFP (c~orhydrates) were introduced in 
saline solution, at final concentrations varying 
from 10m6 to 5 x IO-‘M. CPZ and TFP were gifts 
from Rhone-Poulenc and Theraplix Laboratories, 
respectively. In preliminary experiments using R 
2457 1 (calmidazolium, Boehringer Mannheim) the 
drug (final concentration 10-6-10-5M) was in- 
troduced in ethanolic solution (final concentration 
of ethanol 0.5%). In this case, results were com- 
pared to controls with ethanol 0.5%. Incubations 
were carried out for l-24 h at 37°C. Cells were 
then extensively washed with a phosphate-buffered 
solution, and LDL binding, internalization and 
degradation studied as in [1,2], using [12’I]LDL (10 
p/ml). LDL was prepared in [6] and iodinated as 
in [7]. The specific radioactivity of the [“‘I]LDL 
was about 200-250 cpm/ng protein. Protein deter- 
mination was done as in [8]. Results are expressed 
in cpm - 10e3 - mg cellular protein-‘, Experiments 
were performed at least 4-times, except for short- 
term incubations (l-4 h), which were in triplicate, 
and experiments with R 24571, which were in 
duplicate. 
3. RESULTS AND DISCUSSION 
It can be seen in table 1 that 24 h incubation of 
cells with CPZ or TFP, at concentrations up to 
2x lo-‘M, resulted in a sharp rise in LDL inter- 
nalization. The maximal effect was obtained with 
10e5M, for which concentration an approximate 
3-fold increase was observed with CPZ, and a 
4-5-fold increase with TFP. Concentrations above 
2 x 10m5M resulted in relative decrease in inter- 
nalization (about SO-60% of controls for TF+ 
3 x 10m5 M or CPZ 5 x low5 M). It can be noted 
Table I 
Effects of trifluoperazine (TFP), chlorpromazine (CPZ) and R 24571 on LDL binding, internalization and degradation 
by cultured human fibroblasts, in relation to drug concentration 
Drugs LDL Binding (4°C) LDL Binding + 
internalization (37°C) 
LDL Degradation 
None 
TFP 
PM 
5 x lO+M 
10-5M 
1.5 x 10-5M 
2 x lo-‘M 
3 x 10-5M 
CPZ 
?M 
5 x 10-6M 
10-5M 
2 x 1O-5M 
5 x 10-5M 
Ethanol 0.5010 
R 24571 in ethanol 0.5% 
lO-6M 
5 x 10-6M 
10-5M 
26.5 + 3.8 (100) 
29.7 rf: 4.3 (112) 
36.0-14.0 (136) 
41.926.2 (158) 
40.3 f 5.3 (152) 
33.924.1 (128) 
22.5 i: 2.8 ( 85) 
28.1 k4.6 (106) 
31.225.2 (118) 
33.41t4.8 (126) 
29.7k3.9 (112) 
23.8k4.1 ( 90) 
1954 30 (100) 
2241t 29 (115) 
565+ 96 (290) 
920 rfi 156 (470) 
795 +- 127 (408) 
624 rt 106 (320) 
ill+ 16 ( 57) 
218+ 26 (112) 
331 f 50 (170) 
499i 60 (256) 
526+ 73 (270) 
127 rt 23 ( 66) 
234+ 37 (100) 
178 f 22 ( 76) 
154k 26 ( 66) 
98k 16( 42) 
490+- 78 (100) 
1264 + 227 (258) 
2400 f 384 (410) 
1666 f 283 (340) 
1063 rt 191 (217) 
137+ 18 ( 28) 
1127 + 191 (230) 
1617 + 255 (330) 
1029t 164 (210) 
171 f 26 ( 35) 
587k 96 (100) 
3222 48 ( 55) 
99+ 17 ( 17) 
53k 9( 9) 
Cells were incubated 24 h with the drugs in a medium containing 10% of lipoprotein-deficient serum. The LDL binding, 
internalization and degradation were studied as in [l] using (‘251]LDL (lOpg/ml, 200-250 cpm/ng). Results are express- 
ed in cpm. 10W3/mg cell protein -I. Experiments were performed at least 4-times for TFP and CPZ, and in duplicate 
for R 24571. Numbers in parentheses are percentages 
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that the LDL-specific binding was also increased 
by CPZ or TFP up to 2 x IO-’ M, but less than 
internalization ( - 1.3-fold increase with CPZ, 
and 1.5-1.7-fold increase with TFP). 
As also shown in table 1, the lysosomal degrada- 
tion of LDL was clearly increased for concentra- 
tions up to 2 x IO-‘M. Increasing the concentra- 
tions over 2 x IO-‘M for TFP, or 3-4.10N5M for 
CPZ resulted in a dramatic decrease in LDL de- 
gradation, as observed in [S] for acetylated-LDL in 
liver cells. It must be noted that the LDL lysosomal 
degradation appears to be more inhibited than the 
internalization, which is consistent with the results 
in [5], but these authors did not study the effects 
of TFP on the high-affinity internalization of 
native LDL. 
The short-term effects (l-4 h incubation) were 
studied with TFP, which was the more effective in 
our system. As shown in table 2, significant in- 
crease in LDL internalization and degradation 
took place within’ the, first hours (- 1.5-fold in- 
crease for 4 h incubation with TFP IO-‘M), 
whereas no effect on the LDL-specific binding was 
found. 
This rapid increase in LDL internalization and 
degradation and the discrepancy between the ef- 
fects of TFP on the LDL binding and internaliza- 
tion suggest that the short-term effects observed 
could be related to a direct action of the drug on 
the cell membrane, which resulted in a change in its 
physical characteristics. Independently of their in- 
teraction with ~almodulin, which is probably not 
very selective [9,10], phenothiazines are known to 
bind to phospholipids [l 11. Thus, we assume that 
these lipophilic drugs could also interact with the 
membrane phospholipids, inducing changes in 
membrane organization. Preliminary studies per- 
formed by fluorescence polarization (using di- 
phenylhexatriene or ,&-parinaric acid as probes) 
demonstrated a rapid and significant decrease in 
the cellular membranes’ microviscosity by in vitro 
treatment of cell suspensions with CPZ or TFP 
(not shown). Such decrease in membrane microvis- 
cosity has been previously reported in synap- 
tosomes treated with CPZ [12]. We think that the 
decrease in membrane microviscosity could ac- 
count for the enhancement of the LDL internaliza- 
tion by low concentrations of phenothiazines, 
especially in short-term, experiments. This pheno- 
menon may be compared to the increase in LDL 
internalization observed in fibroblasts treated with 
polyunsaturated fatty acids [13], which are also 
known to increase the membr~e ‘fluidity’ 1141. 
For concentrations above 2-3 x 10m5M, the 
decrease in LDL internalization and degradation is 
probably related to the inhibitory effect of pheno- 
thiazines on calmodulin-dependent processes 
[15,16]. In this range (10-5-10-4M), TFP has been 
shown to inhibit the receptor-mediated endoc~osis 
[4] and the degradation of acetylated-LDL by liver 
cells [5]. Such effects also occurred in our ex- 
perimental system for TFP concentrations over 
2 x lOI’M or CPZ concentrations over 3-4 x 10e5 
M. In preliminary experiments with R 24571, the 
Table 2 
Short-term effects of trifluoperazine (TFP) 10m5 M on LDL binding, internalization and degrada- 
tion by cultured human fibroblasts 
Drug LDL Binding (4“C) LDL Binding + 
internalization (37°C) 
LDL Degradation 
None 24.3 + 3.2 (100) 182rt25 (100) 465k 74 (100) 
lh 23.8k3.4 ( 98) 203+28 (112) 502& 80 (108) 
2h 22.5k3.2 ( 93) 218t33 (120) 530+ 68 (114) 
3h 24.7 k 3.6 (102) 247 + 40 (I 36) 669& 98 (144) 
4h 26.8k4.2 (110) 281+37 (154) 7574 120 (163) 
Prior to experiments, cells were incubated 24 h in a medium containing 10070 lipoprotein-deficient 
serum. After incubation for l-4 h with TFP 1O-5 M, cells were washed and LDL binding, inter- 
nalization and degradation studied as in [l] using [1251]LDL (10 pg/ml, 200-250 cpm/ng). Results 
are expressed in cpm . 10-3fmg cell protein -I_ Experiments were performed in triplicate. Numbers 
in parentheses are percentages 
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most potent and selective calmodulin inhibitor 
[17], concentrations of 10e6 to lo-‘MM, only caused 
a decrease (about 50-60% of controls) in LDL in- 
ternalization, and a strong inhibition of the LDL 
lysosomal degradation (about 10% of controls for 
R 24571 10w5M, see table 1). Thus, we assume that 
the stimulation of LDL internalization observed 
with low concentrations of phenothiazines is main- 
ly related to the decrease in membrane microvis- 
cosity, whereas the inhibitory effect found for con- 
centrations over 2 x 10m5M is especially related to 
the inhibition of calmodulin-dependent processes. 
The moderate increase in LDL binding which 
took place in 24 h incubations, mainly with TFP, 
is probably related to late perturbations in cell 
metabolism. In [ 181 we described alterations in 
LDL binding and internalization by cyclic-AMP 
and drugs which affect its intracellular concentra- 
tion in cultured human fibroblasts. Adenylate 
cyclase has been shown to be related to calmodulin 
in various tissues: brain [19], pancreas islets [20], 
adrenal medulla [21], or even in procaryotic cells 
[22], and thus affected by calmodulin effecters 
such as phenothiazines. There is still no report con- 
cerning the effects of phenothiazines on the intra- 
cellular CAMP level in fibroblasts, but in some ex- 
periments we found that CAMP partially counter- 
acted the increase in LDL binding and internaliza- 
tion induced by TFP (24 h incubation with 
dibutyryl CAMP 10e3M +TFP 10e5M, 2 experi- 
ments: a 4.5-fold increase was observed with TFP 
alone, whereas only a 2-fold increase was found 
with TFP + CAMP). Thus, some of the late effects 
of phenothiazines on the LDL metabolism could 
be at least partially related to alterations in the 
CAMP intracellular level. 
To our knowledge, the stimulation of LDL in- 
ternalization and degradation by low concentra- 
tions of phenothiazines (10-6-10-5M) has not been 
reported. We assume that it is probably related to 
the lipophilic properties of these drugs, and that a 
similar phenomenon could be involved, at least 
partially, in the hypocholesterolemic effect of 
other lipophilic drugs such as suloctidil, which has 
also been reported to decrease membrane micro- 
viscosity [ 121. This concept could be of use for syn- 
thesis of new hypocholesterolemic agents which 
enhance the LDL peripheral catabolism by means 
of a decrease in cell membrane microviscosity. 
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